Search Within

Sean McCarthy Devlin

Formats
  1. Meeting Abstract (375)
  2. Journal Article (219)
  3. Research Letter (16)
  4. Correspondence (5)
  5. Editorial (1)
  6. Review (1)
Groups
  1. Biostatistics Service (617)
  2. Epidemiology and Biostatistics (617)
  3. Department of Medicine (588)
  4. Hematologic Malignancies, Division of (587)
  5. Center for Hematologic Malignancies (585)
  6. Bone Marrow Transplant (470)

More Groups

People
  1. Sergio Giralt (380)
  2. Miguel-Angel Perales (303)
  3. Gunjan Shah (187)
  4. Molly Maloy (162)
  5. Parastoo Dahi (161)
  6. Michael Scordo (152)

More People

Years
  1. 2025 (19)
  2. 2024 (35)
  3. 2023 (52)
  4. 2022 (42)
  5. 2021 (36)
  6. 2020 (56)

More Years

Publications
  1. Blood (204)
  2. Biology of Blood and Marrow Transplantation (133)
  3. Bone Marrow Transplantation (51)
  4. Blood Advances (28)
  5. Transplantation and Cellular Therapy (25)
  6. Journal of Clinical Oncology (16)

More Publications

Publishers
  1. American Society of Hematology (232)
  2. Elsevier Inc. (176)
  3. Nature Publishing Group (74)
  4. American Society of Clinical Oncology (16)
  5. Taylor & Francis Group (16)
  6. American Association for Cancer Research (12)

More Publishers

Results (617)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • SETBP1 and NRAS mutations are frequent events in post-myeloproliferative neoplasm acute myeloid leukemia (post-MPN AML) lacking JAK-STAT activating mutations
    Meeting Abstract

    Menghrajani, K.; Rapaport, F.; McNamara, C. J.; Devlin, S. M.; Famulare, C.; Patel, M.; Medina, J.; Sandy, L.; Kosiorek, H.; Singer Weinberg, R.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • MRD response-driven phase I/II study for newly diagnosed multiple myeloma patients using higher doses of twice-weekly carfilzomib (45 and 56 mg/m2) in combination with lenalidomide and dexamethasone
    Meeting Abstract

    Korde, N.; Mailankody, S.; Smith, E. L.; Lendvai, N.; Hassoun, H.; Lesokhin, A.; Hultcrantz, M.; Chung, D. J.; Shah, G. L.; Koehne, G.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Venetoclax combined with either a hypomethylating agent or low-dose cytarabine shows activity in relapsed and refractory myeloid malignancies
    Meeting Abstract

    Goldberg, A. D.; Horvat, T. Z.; Hsu, M.; Devlin, S. M.; Cuello, B. M.; Daley, R. J.; King, A. C.; Buie, L. W.; Glass, J. L.; Mauro, M. J.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Widespread use of measurable residual disease in acute myeloid leukemia practice
    Meeting Abstract

    Epstein-Peterson, Z. D.; Devlin, S. M.; Stein, E. M.; Estey, E. H.; Tallman, M. S.
    Blood (2017)

    Fulltext@MSK | Save
  • Myeloid malignancies following luminal gastrointestinal cancer: High incidence of deletion 5q and DNTM3A mutations
    Meeting Abstract

    Epstein-Peterson, Z. D.; Devlin, S. M.; Stein, E. M.; Klimek, V. M.; Saltz, L. B.; Tallman, M. S.
    Blood (2017)

    Fulltext@MSK | Save
  • Characterizing ionizing radiation exposure after T-cell depleted allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Cho, C.; Maloy, M.; Devlin, S. M.; Aras, O.; Castro-Malaspina, H. R.; Dauer, L. T.; Jakubowski, A. A.; O'Reilly, R. J.; Papadopoulos, E. B.; Perales, M. A.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Efficacy of donor lymphocyte infusion in CD34+ selected allogeneic hematopoietic stem cell transplant for myeloid and lymphoid malignancies: A single center experience
    Meeting Abstract

    Bryant, A.; Devlin, S. M.; Castro-Malaspina, H. R.; Jakubowski, A. A.; Maloy, M.; Papadopoulos, E. B.; Giralt, S. A.; Perales, M. A.
    Blood (2017)

    Fulltext@MSK | Save
  • Quantitative analysis of T1-weighted MRI images as a surrogate for fat content does not correlate with response or survival
    Meeting Abstract

    Amer, A.; Gunjan, S.; Benjamin, D.; Sean, D.; Molly, M.; Yousef, M.; David, C.; Guenther, K.; Nikoletta, L.; Heather, L.; more...
    Bone Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Vaccines are safe and effective after T-cell depleted CD34-selected allogeneic hematopoietic stem cell transplantation (Allo HCT)
    Meeting Abstract

    Malard, F.; Shah, G. L.; Seier, K.; Cho, C.; Devlin, S. M.; Maloy, M.; Borrill, T.; Palazzo, M.; van den Brink, M.; Perales, M. A.
    Bone Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: A landmark analysis
    Journal Article

    Cho, C.; Hsu, M.; Barba, P.; Maloy, M. A.; Avecilla, S. T.; Barker, J. N.; Castro-Malaspina, H.; Giralt, S. A.; Jakubowski, A. A.; Koehne, G.; more...
    Bone Marrow Transplantation (2017)

    Fulltext@MSK | Save